Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07073521 · ClinicalTrials.gov registry record · NA
Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision Loss
A NA study of Depression, Anxiety and Visual Impairment, sponsored by The Chicago Lighthouse.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT07073521: Recruiting NA study of Depression, Anxiety and Visual Impairment, sponsored by The Chicago Lighthouse.
NCT07073521 is a NA study of Depression, Anxiety and Visual Impairment that is actively recruiting participants, run by The Chicago Lighthouse. The registered enrollment target is 45 participants, below the 424-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07073521, a NA study of Depression, Anxiety and Visual Impairment, is actively recruiting participants, sponsored by The Chicago Lighthouse.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to develop and pilot test a therapeutic strategy combining cognitive behavioral therapy (CBT) with mindfulness practices tailored for individuals adjusting to vision loss. The study will begin with focus groups to inform the design of the intervention. Participants will complete brief surveys on their background and experiences with vision loss prior to attending a focus group, and some may be invited to a second session to provide additional feedback before preliminary testing begins. In the pilot phase, participants will attend weekly group therapy sessions using the developed intervention and complete assessments before and after the program, including questions about vision status, demographics, and experiences with vision loss.
Primary Outcome
The AVL is a 24-item self-report questionnaire rated on a 5-point Likert scale. Items assess emotional and psychosocial adjustment to vision loss. Scores range from 1 to 5, with higher scores indicating better adaptation. Some items are reverse-scored.
Conditions Studied
Interventions
- BEHAVIORAL Integrated Cognitive Behavioral Therapy (CBT) & Mindfulness Group Intervention for Adjustment to Vision Loss
Study Locations (1)
Illinois
- The Chicago Lighthouse - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2025-07-14 |
| Est. Completion | 2027-07-13 |
| Phase | NA |
What NCT07073521 shows while recruiting
NCT07073521 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 424-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (89% lower).
The record links to 8 conditions, with Depression, Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Integrated Cognitive Behavioral Therapy (CBT) & Mindfulness Group Intervention for Adjustment to Vision Loss is the first listed.
NCT07073521 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07073521 about?
NCT07073521 is a clinical study titled "Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision Loss". The goal of this study is to develop and pilot test a therapeutic strategy combining cognitive behavioral therapy (CBT) with mindfulness practices tailored for individuals adjusting to vision loss. The study will begin with focus groups to inform the design of the intervention. Participants will com...
What is the current status of trial NCT07073521?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-07-14. Estimated completion is 2027-07-13.
What conditions does trial NCT07073521 study?
This clinical trial studies the following conditions: Depression, Anxiety, Visual Impairment, Adjustment, Adjustment Disorder With Anxious Mood, Blindness, Acquired.
What interventions are being tested in trial NCT07073521?
The interventions under investigation include: Integrated Cognitive Behavioral Therapy (CBT) & Mindfulness Group Intervention for Adjustment to Vision Loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT07073521?
This trial is sponsored by The Chicago Lighthouse, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07073521 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression, Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07073521's enrollment target sits among peer trials
45 32nd of 40 higher than 8 of 40 other Depression, Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression, Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
Test of Target Engagement of Ambiguity Aversion
RECRUITING · NA
-
SUpport From PEeRs to Expand Access Study - Community
RECRUITING · NA
-
Building Connections
RECRUITING · NA
-
Just-In-Time Adaptive Interventions (JITAIs) in a Digital Mental Health Intervention for Middle-Aged and Older Adults With Chronic Pain
RECRUITING · NA
-
Harlem Strong Mental Health Coalition
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI